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Background
Potentially modifiable risk factors for developing dementia have
been identified. However, risk factors for increased mortality in
patients with diagnosed dementia are not well understood.
Identifying factors that influence prognosis would help clinicians
plan care and address unmet needs.
Aims
To investigate diagnosed depression and sociodemographic
factors as predictors of mortality in patients with dementia in UK
secondary clinical care services.
Method
We conducted a cohort study of patients with a dementia diag-
nosis in an electronic health records database in a UK National
Health Service mental health trust.
Results
In 3374 patients with 10 856 person-years of follow-up, comorbid
depression was not associated with mortality (adjusted hazard
ratio 0.94; 95% CI 0.71–1.24). Single patients had higher mortality
than those who were married (adjusted hazard ratio 1.25; 95% CI
1.03–1.50). Patients of Asian ethnicity had lower mortality rates
than White British patients (adjusted hazard ratio 0.50; 95% CI
0.34–0.73).
Conclusions
Clinically diagnosed depression does not increase mortality in
patients with dementia. Patients who are single are a potential
high-mortality risk group. Lower mortality rates in Asian patients
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Over 700 000 people in England and Wales were estimated to have
dementia in 2016, and recent projections suggest this will rise to
more than 1.2 million by 2040.1 Several modifiable risk factors for
developing dementia have been identified.2 However, risk factors
for earlier mortality among those already diagnosed with dementia
are less well understood.
Depression is common in people with dementia and,3 in the
general population, there is evidence that depression increases
mortality rates.4 However, evidence for an influence of depres-
sion on mortality in patients with dementia is inconclusive. A
few studies report increased mortality rates in patients with
dementia and depression,5–8 but these are either small and
might lack statistical power,7,8 or use select populations unrepre-
sentative of broader clinical care.5,6 Many studies report no asso-
ciation between depression and mortality in patients with
dementia, or only very weak evidence of an association.9–11
Most studies also use screening measures based on individual
depressive symptoms, rather than clinically verified diagno-
ses.12,13 No large study has been conducted of the association
between diagnosed depression and mortality in patients with
dementia in UK clinical care. Given that depression can be
screened for and treated, addressing this knowledge gap has
important clinical implications.
Several studies in the USA report that patients with dementia
from minority ethnic groups have lower mortality rates after diag-
nosis.9,14–16 A recent study of 59 494 healthcare patients with
dementia in Northern California found lower mortality rates in
ethnic minority groups, including Black and Asian Americans.16
To our knowledge, there has only been one UK investigation of
ethnic differences in mortality rates after dementia diagnosis.13
This study found lower mortality rates in ethnic minority groups,
but only investigated participants with mild dementia. There is
also little research on other sociodemographic influences onmortal-
ity in patients with dementia, such as marital status.
In this study we used electronic health records from a large
mental health trust in London (UK), to investigate diagnosed
depression and sociodemographic factors as predictors of mortality
in patients with dementia.
Method
Participants
The sample consisted of secondary mental healthcare patients from
Camden and Islington National Health Service (NHS) Foundation
Trust in London (UK). The Trust provides mental health services
to around 440 000 individuals in two inner-city London boroughs
(Camden and Islington). Patients were identified by the Clinical
Record Interactive Search (CRIS) system – a platform developed
to enable searches in anonymised routine electronic health
records.17 The Camden and Islington CRIS database contains anon-
ymised information on more than 117 000 mental health patients
from 2008 to 2016.
Approval to use CRIS in Camden and Islington was received
from the National Research Ethics Service Committee East of
England – Cambridge Central (ethical approval number – 14/EE/
0177). The study itself was approved by Camden and Islington
NHS Trust Research Review Committee. Informed consent was
not obtained as data were pseudonymised and use of the data
approved by the National Research Ethics Service Committee East
of England – Cambridge Central.
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In all NHS trusts, deceased patients are identified on amonthly basis
via the ‘Service User Death Report’ by their NHS number, and this
information is fed back into the electronic health records.
Mental health diagnoses
Diagnoses administered in UK secondary care are routinely
recorded according to ICD-10 (international classification of dis-
eases, 10th revision) criteria. We derived dementia diagnoses with
ICD-10 codes F00–F03, and G30 for Alzheimer’s disease. We iden-
tified depression diagnoses in two ways. First, we derived diagnoses
of major depression with the ICD-10 codes F32.0–F32.9 and F33.0–
F33.9. We included depression diagnoses made 6 months before the
time of dementia diagnosis (to approximate the average depressive
episode duration),18 or anytime afterward. Second, we used natural
language processing (NLP) techniques to extract indicators of
depression diagnoses from free text, in those not given an ICD-10
depression code. These NLP techniques have been developed and
evaluated for extracting knowledge from unstructured text data.19
Themain NLP technique used in CRIS has been information extrac-
tion, where unstructured text is converted into structured tables.19
We used the NLP technique to identify any additional depression
diagnoses that might have been missed by the ICD-10 codes. Our
depression diagnosis variable (yes/no) consisted of ICD-10 depres-
sion diagnoses plus the additional depression diagnoses identified
by NLP, among those not assigned an ICD-10 depression code.
We also used a NLP app to extract data on antidepressant use 6
months before the dementia diagnosis or anytime afterward. We
investigated antidepressant use (yes/no) as a separate variable
because antidepressants may be prescribed to patients with demen-
tia for indications other than depression.
Social deprivation
The Index ofMultiple Deprivation (IMD) combines national census
information from 38 indicators into seven domains of deprivation
(income; employment; health and disability; education, skills, and
training; barriers to housing and services; living environment and
crime).20 This results in one deprivation score for 32 482 ‘lower
super output areas’ in England, geographical units used for the
reporting of neighbourhood-level statistics. Each area has an
average population of around 1500 people (about 400 households).
Patients’ addresses are recorded in routinely collected clinical data.
We obtained IMD scores by linking the lower super output area
code of each patient’s permanent address to 2011 national data.
Higher IMD scores indicate more deprived areas. IMD scores
were classified into tertiles, with the lowest (least deprived) category
as the reference.
Cognitive impairment
The Mini-Mental State Examination (MMSE) is frequently used by
health professionals as a brief method of assessing cognitive impair-
ment. Patients respond to 11 items, with possible scores ranging
from 0 to 30. Lower scores indicate more severe cognitive impair-
ment.21 MMSE scores were extracted from the CRIS database by
NLP. We used the MMSE administered closest to the date of
dementia diagnosis classified into tertiles, with the least severe
tertile (highest scores) as the reference.
Other demographics
We extracted gender, marital status and ethnicity. We codedmarital
status as married, divorced (including separated), widowed or single
(never married). Ethnicity was coded as White British, White other,
Asian, Black or ‘mixed and other’ including Chinese.
Statistical analyses
All analyses were conducted with STATA, version 11.We examined
longitudinal associations with univariable and multivariable Cox
survival models, to calculate hazard ratios and 95% confidence
intervals. Time was defined as the number of days from date of
dementia diagnosis to date of death, or the end of the follow-up
period. This approach accounts for differences in follow-up times
between patients. Our study was restricted to clinical data collected
between 2008 and 2016 because electronic records began in 2008.
However, some individuals have longer follow-up periods because
they were diagnosed before 2008 but their data was migrated to
the electronic health record.
Missing data
There were missing data on ethnicity (8%), marital status (11%) and
IMD (7%). Cumulatively, 20% of the sample were missing data on at
least one of these variables. Missing data were related to our
outcome and might have introduced bias, so we conducted a sensi-
tivity analysis with multiply imputed data. We conducted multiple
imputation by chained equations, using the ice command in
STATA, to impute missing ethnicity, marital status and IMD
data. We used all data in the analysis model to predict missing
data. Data were then analysed across 25 imputed data-sets, com-
bined by Rubin’s rules.22
Results
We identified 4684 patients diagnosed with dementia. Patients
without at least one MMSE were excluded from the outset, so that
models could be adjusted for cognitive impairment. Fig. 1 shows
the flow of these participants through the study. After including
patients with data on all other study variables, the sample size was
3374.
The characteristics of the sample with complete data are pre-
sented in Table 1. Depression was identified in 247 (7%) patients.
Of these, 186 (75%) were identified by ICD-10 codes and an add-
itional 61 (25%) by the NLP app. Of those with depression, 76%
had been prescribed antidepressants in the 6 months before or
anytime after their dementia diagnosis. Only 18% of patients pre-
scribed antidepressants also had a depression diagnosis. There
was evidence that patients with depression had higher MMSE
scores (indicating better cognitive function) at the time of dementia
diagnosis. The mean MMSE score was 21.95 (s.d. 5.86) for patients
with depression and 20.41 (s.d. 6.20) for patients without depression
(mean difference −1.54; 95% CI −2.43 to −0.74). Patients with
depression also had a lower age at diagnosis of dementia. The
mean age at diagnosis of dementia was 78.37 (s.d. 8.80) for patients
with depression and 81.53 (s.d. 7.84) for patients without depression
(mean difference 3.16; 95% CI 2.13–4.18).
Patients were followed for a total of 10 856 person-years, with
the length of follow-up ranging from 0.4 to 14.28 years (mean
3.22; s.d. 2.16). There was no evidence that length of follow-up dif-
fered according to depression. The mean follow-up time was 3.23
years (s.d. 2.23) for patients with depression and 3.22 years (s.d.
2.15) for patients without depression. By the end of follow-up,
929 patients (28%) had died. Individuals in the complete case
sample had a lower mortality rate than those with missing data
(hazard ratio 0.69; 95% CI 0.58–0.80).
Associations between risk factors and mortality are presented in




•   No diagnosis of dementia
Sample (N = 4218) of patients with
dementia and at least one MMSE
Diagnosis of dementia (N= 4684)
assessed for MMSE
Excluded (N= 466)
•   No MMSE
116,936 patients in CRIS assessed for
a diagnosis of dementia between 2008
and 2016
Final study sample (N= 3374) of patients
with dementia and at least one MMSE, who
had complete data on all study variables
Excluded (N= 844)
•   Missing data on one or more
     study variables 
Fig. 1 Sample flowchart.
CRIS, Clinical Record Interactive Search; MMSE, Mini-Mental State Examination.
Table 1 Characteristics of study sample and predictors of mortality (N = 3374)
Characteristic N (%) Hazard ratio (95% CI); P valuea Hazard ratio (95% CI); P valueb
Gender
Male 1329 (39) Ref Ref
Female 2045 (61) 0.72 (0.63–0.82); P < 0.0001 0.62 (0.54–0.72) P < 0.0001
Ethnicity
White British 1841 (55) Ref Ref
White other 852 (25) 0.84 (0.72–0.98); P = 0.026 0.80 (0.69–0.94); P = 0.007
Asian 183 (5) 0.47 (0.32–0.69); P < 0.0001 0.50 (0.34–0.73); P < 0.0001
Black 344 (10) 0.97 (0.78–1.21); P = 0.803 0.91 (0.73–1.14); P = 0.424
Mixed and other 154 (5) 0.59 (0.40–0.97); P= 0.008 0.63 (0.43–0.94); P= 0.022
Marital status
Married 1101 (33) Ref Ref
Divorced 407 (12) 0.95 (0.76–1.19); P = 0.638 1.21 (0.96–1.52); P= 0.107
Widowed 1239 (37) 1.01 (0.87–1.18); P = 0.856 1.02 (0.86–1.21); P= 0.825
Single 627 (19) 1.12 (0.93–1.35); P= 0.233 1.25 (1.03–1.50); P = 0.022
Age at diagnosis, years
<65 98 (3) Ref Ref
66–75 558 (17) 1.78 (0.96–3.32); P= 0.069 2.06 (1.10–3.86); P= 0.024
76–85 1549 (46) 2.65 (1.45–4.82); P= 0.001 3.07 (1.68–5.63); P < 0.0001
>85 1169 (35) 4.50 (2.47–8.19); P < 0.0001 5.47 (3.00–10.03); P < 0.0001
IMD tertiles
Least deprived (1.9–26.6) 1156 (34) Ref Ref
Middle (26.7–36.4) 1107 (33) 1.07 (0.91–1.25); P= 0.401 1.13 (0.96–1.33); P= 0.139
Most deprived (36.5–87.8) 1111 (33) 1.17 (1.00–1.36); P= 0.054 1.23 (1.05–1.44); P= 0.012
MMSE tertiles
Least impaired (24–30) 958 (28) Ref Ref
Moderate (18–23) 1157 (34) 1.41 (1.19–1.66); P < 0.0001 1.43 (1.21–1.69); P < 0.0001
Most impaired (0–17) 1259 (37) 1.75 (1.49–2.05); P < 0.0001 1.92 (1.62–2.26); P < 0.0001
Depression
No 3127 (93) Ref Ref
Yes 247 (7) 0.82 (0.63–1.08); P= 0.154 0.94 (0.71–1.24); P= 0.645
Antidepressant use
No 2321 (69) Ref Ref
Yes 1053 (31) 1.01 (0.88–1.17); P= 0.838 1.15 (0.99–1.33); P= 0.059
IMD, Index of Multiple Deprivation; MMSE, Mini-Mental State Examination; Ref, reference value.
a. Univariable models.
b. Multivariable model mutually adjusted for all other variables in the table.
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mortality (adjusted hazard ratio 0.94; 95% CI 0.71–1.24). We found
evidence that patients who reported being single had a higher mor-
tality rate than those who were married (adjusted hazard ratio 1.25;
95% CI 1.03–1.50). Mortality rates for patients who were widowed
or divorced did not differ from the mortality rate for those who were
married. Mortality rates were also higher in patients living in the
most deprived comparted to the least deprived areas (adjusted
hazard ratio 1.23; 95% CI 1.05–1.44), and in those with the most
compared with the least cognitive impairment (adjusted hazard
ratio 1.92; 95% CI 1.62–2.26). Mortality was also higher in patients
who were older at the time of diagnosis (adjusted hazard ratio for
those aged over 85 years compared with those aged under 65
years, 5.47; 95% CI 3.00–10.03). Mortality rates were lower in
women than men (adjusted hazard ratio 0.62; 95% CI 0.54–0.72)
and Asian patients (adjusted hazard ratio 0.50; 95% CI 0.34–0.73)
compared with White British patients. There was some weak evi-
dence of a small association between antidepressant use andmortal-
ity (adjusted hazard ratio 1.15; 95% CI 1.00–1.33). Results based on
the multiply imputed sample were very similar (see Supplementary
Table 1, available at https://doi.org/10.1192/bjp.2018.86).
Discussion
We found no evidence that clinically diagnosed depression was
associated with mortality in people with dementia in a large
mental health trust in London (UK). We found evidence that
Asian patients with dementia had reducedmortality rates compared
with White British patients, and that single patients with dementia
had higher mortality rates compared with those who were married.
Our other findings confirm associations already established in this
population, that male gender, older age, more severe cognitive
impairment and living in more deprived areas are associated with
increased mortality rates.2,23
Strengths and limitations
To our knowledge, this is the largest study to test the association
between clinically diagnosed depression and mortality in people with
dementia in UK clinical care. Our clinical cohort enabled access to a
large number of patients with clinically diagnosed dementia. In popu-
lation-based cohorts, there is evidence that people with dementia or
preclinical stages of dementia have higher drop-out rates.24 An advan-
tage of routinely collected clinical cohorts is that patient attrition is
reduced because of continued need for clinical care. The study
settingalsomeans thatour findings aredirectly relevant to themanage-
ment of dementia in real-world clinical practice in the UK.
Our study has several limitations. First, data obtained from
routine electronic health records are not collected for research pur-
poses, which can introduce certain issues. Patients with dementia
are not routinely screened for depression in UK secondary care
so it is possible that depression prevalence was underestimated in
our sample. We had a relatively small number of participants
with depression (n = 247). However, our total sample size was
large and because we used a cohort with dementia, the mortality
rate was high (>900). This large number of outcome events would
have increased our statistical power. Although we found no evi-
dence for an association between depression and mortality, it is
important to note that the confidence intervals were wide.
Replication in a different cohort would strengthen our conclusion
that depression does not influence mortality in patients with
dementia. It is also possible that depression diagnoses were assigned
to patients with more severe depression, with less severe depression
omitted. However, we cannot be certain that depression diagnoses
were missed. Comorbidity between dementia and depression has
been well documented, and clinicians are likely to be aware of
this. Our investigation is also directly relevant to how depression
is diagnosed in UK secondary care for dementia.
Our measurement of social deprivation relied on data obtained
from the IMD. This relates to area-level census information, so may
not completely capture individual level socioeconomic status. We
also lacked reliable information on physical health around the time
of dementia diagnosis. Clinician ratings of physical health were avail-
able, but these were collected at varying time-points over the study
period, and would have increased the amount of missing data.
Finally, it is possible that our results are not generalisable to
other clinical settings in the UK or abroad. However, similar asso-
ciations for depression and ethnicity have been reported in large
studies in the USA (see below).
Depression and mortality in people with dementia
We found no evidence for an association between diagnosed depres-
sion and mortality in patients with dementia. This is consistent with
several other studies of patients with dementia.9–11 However, there
is good evidence for an association between depression and mortal-
ity in the general population.4 Many people with depression in our
sample are likely to have had depressive episodes before. Given
depression is associated with premature mortality, many people
with depression may have died before the study or before the
period of peak onset for dementia. This would mean that people
with depression who survive to the main dementia risk period are
no more likely to die than people without depression who also
survive to this period. It is also possible that people with depression
might be diagnosed with dementia at an earlier pathological stage,
which could contribute to their better than expected survival.
MMSE scores at the time of dementia diagnosis were higher (indi-
cating better cognitive function) in patients with depression, and
their age at diagnosis of dementia was lower.
We found some evidence of a small association between anti-
depressant use and mortality, consistent with another UK study.13
The prevalence of antidepressant use was 31%whereas the prevalence
of depression was 7%. It is therefore possible that antidepressants are
prescribed to patients with dementia for reasons other than depressed
mood. This has been observed in the general population, with evi-
dence that only 55% of antidepressant prescriptions are for depres-
sion and that they are commonly prescribed for anxiety, insomnia,
pain and panic.25 It is possible that patients with dementia who
were receiving antidepressants had multiple other comorbidities
that could have resulted in increased mortality. Further research is
therefore needed to confirm any potential association between anti-
depressants and mortality in patients with dementia.
Ethnicity and mortality in people with dementia
Our finding that Asian people with dementia had lower mortality
rates than White British people is consistent with two large
studies of patients with dementia in the USA, and one in the
UK.9,13,16 Inconsistent with the studies in the USA, we found no
evidence of reduced mortality rates among Black people with
dementia. Higher mortality rates among White people relative
to ethnic minority groups are not unique to dementia.16 The
‘mortality-cross-over’ has been well documented in the USA
general population; people from ethnic minorities are more likely to
die than White people until around 70 to 80 years of age. After this,
mortality curves ‘cross-over’, and White people are more likely to
die.16,26 One potential explanation is that, because ethnic minorities
experience higher mortality rates at younger ages, a more socially
and physically advantaged population remains to old age.26 To our
knowledge, there are less UK data on this, but the mortality cross-
over could be one explanation for our observed association.
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Marital status and mortality in people with dementia
As far as we are aware, our study is the first to report that being
single is associated with a higher mortality rate in patients with
dementia. In contrast, we found no evidence that patients who
were widowed or divorced had higher mortality rates. Our finding
that being single was associated with higher mortality rates in
patients with dementia should be interpreted with caution; our stat-
istical evidence was not strong, and replication in another sample
would give greater confidence in the finding. However, our evidence
of increased mortality rates in single people is consistent with
studies of other chronic diseases such as cancer.27 There is also evi-
dence that, in the general population, married people tend to live
longer.28 One likely explanation is the health benefits of increased
social support. For example, spouses are likely to encourage each
other to lead healthy lifestyles and seek healthcare. It is also possible
that more frequent social interactions increase cognitive reserve,
which could slow the progression of dementia.2
Previous studies have reported that widowed and divorced
people also have higher mortality rates than married people, but
the effect seems consistently strongest for those who are never
married.27 Our finding that being widowed or divorced was not
associated with higher mortality rates could be because widowed
or divorced patients had developed more or better social support
networks and healthier lifestyles during the years they were married.
A potential alternative explanation for our association between
single marital status and increased mortality rates is the selection of
healthier individuals into marriage. However, these would need to
be lifestyle and health differences that existed before marriage and
were associated with risk of dementia.
Implications
Our evidence is that comorbid depression does not increase mortal-
ity rates in people with dementia. Our finding of lower mortality
rates in Asian patients with dementia, if partly because of mortality
cross-over, draws attention to the disparities in health outcomes
that affect ethnic minority groups in the UK earlier in life. One
way to address this mortality differential in patients with dementia
would be to address social inequalities in health outcomes for ethnic
minority groups earlier in life. Our findings also suggest that
patients with dementia who are single are a higher-risk group
who are more vulnerable to earlier mortality and might benefit
from extra social support.
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